The invention provides compositions and methods for treating pulmonaryconditions and for reducing the negative effects of pulmonary inflammation.Such compositions and methods employ protease inhibitors and a lung surfactantmixture. The compositions and methods can also include lipase inhibitors (e.g.a phospholipase inhibitors) and anti-oxidants.